Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.

Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism. J Biol Chem. 2016 09 09; 291(37):19517-31.

View in: PubMed

subject areas

Animals
Arginase
Blood-Brain Barrier
Chemokine CCL17
Disease Models, Animal
Disease Susceptibility
Female
Interleukin-10
Lectins, C-Type
Macrophages
Malaria, Cerebral
Male
Mannose-Binding Lectins
Mice
Mice, Knockout
Neutrophils
Plasmodium berghei
Receptor, Cannabinoid, CB2
Receptors, Cell Surface

authors with profiles

Andrea Dlugos